

Pharma Latch: Intradermal Injections: Solved
Thursday, January 25, 2024 11:00 AM to 11:15 AM · 15 min. (Africa/Abidjan)
Start-Up Hub J9 - J40
Start-Up Pitches
Information
Pharma Latch have developed a series of innovative HCP and self-administration intradermal injection devices, based on a core platform technology. Our devices ensure consistent needle-depth penetration and complete dose delivery to the intended compartment and can inject high volume and viscosity formulations (up to: 3 mL, 60 cP).
